Alesta Therapeutics
PrivateLast Round
Series A
Jan 8, 2025
Total Funding Raised
$67M
Momentum Score
25 /100
Company Overview
Alesta Therapeutics is a biotechnology company developing novel oral small molecule therapies for underserved rare diseases such as hypophosphatasia (HPP) and Charcot-Marie-Tooth (CMT).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alesta Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Alesta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 8, 2025 |
Alesta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Droia Ventures | Series A |
| Thuja Capital | Series A |
| Novartis Venture Fund | Series A |
| Frazier Life Sciences | Series A |
| RV Invest | Series A |
| RTW Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Grew 17% QoQ, from 18 to 21 employees.
- Jan 14, 2026
Presenting corporate and clinical update at JP Morgan Healthcare Conference.
Alesta Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alesta Therapeutics's valuation, stock price, and market status.
